Oncology Medical News about Carcinoma, Non-Small-Cell Lung Lung Lung Neoplasms

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Cancer Investigation, 10/23/09

Jazieh AR et al. – This study aim was to determine the efficacy and safety of the combination of Gemcitabine 1000mg/m^2 day 1 & 8 and Irinotecan 100 mg/m^2 day 1 & 8 with escalating dose of thalidomide in chemonaive patients with advanced non–small cell lung cancer. The 1 year and 2 year survival rates were 36% and 27%, respectively. This combination is active in advanced NSCLC with manageable toxicity profile.

<< Previous
Phase I trial of vinflunine and pemetrexed in refractory solid...

Next >>
Initial cytoreductive treatment with thalidomide plus bolus...

Expression of ERCC1 and class IIIbeta tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer
Pathology International, 10/30/09 Relevance Score: 96%

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms
Annals of Thoracic Surgery, 10/23/09 Relevance Score: 96%

Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue
Expert Review of Anticancer Therapy, 10/22/09 Relevance Score: 96%

hsa-miR-125a-5p Enhances Invasion in Non-small Cell Lung Carcinoma Cell Lines by Upregulating Rock-1
Chinese Journal of Lung Cancer, 10/20/09 Relevance Score: 96%

Expression of Cancer-Testis Antigens MAGE-A3/6 and NY-ESO-1 in Non-Small-Cell Lung Carcinomas and Their Relationship with Immune Cell Infiltration
Lung, 10/05/09 Relevance Score: 96%